Most Read Articles
30 Oct 2017
Children with autism spectrum disorders (ASD) appear to have significantly altered gut mucosal mitochondrial function compared with controls and other children with nonspecific gastrointestinal symptoms, a recent study shows.
29 Aug 2015
Non-operative management of acute pancreatitis substantially decreased exocrine and endocrine dysfunction compared with operative method, a recent study shows.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Aug 2015
Genetic mutations in acute and recurrent acute pancreatitis elevates risk of chronic pancreatitis development based on single-centre study.

GPs in co-management of IBD: The follow-up phase

02 Oct 2017
If implemented correctly, the physician associates (PA) could really aid in taking some of the pressure off doctors.
Last August, the article 'Role of General Practitioners in Early Detection of Inflammatory Bowel Disease' highlighted proper screening and early specialist referral by the general practitioner (GP) as vital components in reducing the burden of inflammatory bowel disease (IBD). This year, the focus is on the role of GPs in co-managing a patient with IBD at the follow-up phase.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
30 Oct 2017
Children with autism spectrum disorders (ASD) appear to have significantly altered gut mucosal mitochondrial function compared with controls and other children with nonspecific gastrointestinal symptoms, a recent study shows.
29 Aug 2015
Non-operative management of acute pancreatitis substantially decreased exocrine and endocrine dysfunction compared with operative method, a recent study shows.
15 Aug 2017
New drug applications approved by US FDA as of 1 - 15 August 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Aug 2015
Genetic mutations in acute and recurrent acute pancreatitis elevates risk of chronic pancreatitis development based on single-centre study.